â– LECTURE OVERVIEW: Epistaxis (nosebleeds) is a common clinical presentation, most commonly originating from a highly vascularized anatomical zone in the anterior nasal septum.
â– ANASTOMOTIC VASCULAR CHANNELS:
1. Kiesselbach's Plexus: A highly dense, planar arterial network located in the anterior-inferior quadrant of the nasal septum, also termed Little's Area.
2. Five Arterial Inlets:
- Anterior Ethmoidal Artery (from the Ophthalmic/Internal Carotid).
- Posterior Ethmoidal Artery (from the Ophthalmic/Internal Carotid).
- Sphenopalatine Artery (terminal branch of the Maxillary/External Carotid).
- Greater Palatine Artery (from the Maxillary/External Carotid).
- Septal Branch of the Superior Labial Artery (from the Facial/External Carotid).
3. Mucosal Vulnerability: The mucosa overlying Kiesselbach's plexus is exceptionally thin and superficial, leaving the vessels unprotected.
â– BIOCHEMICAL MECHANISMS:
At the molecular level, enzyme kinetics govern reaction rates. Competitive inhibitors raise apparent Michaelis constants without changing maximum speed, whereas noncompetitive inhibitors decrease maximum speed directly.
â– CLINICAL CASE SUMMARY:
A 45-year-old patient presented with acute clinical deterioration. Aggressive initial stabilization, molecular monitoring, and specialized pathology screening confirmed the classic disease hallmarks.
[HY-BOARD-1030]
🌟 Dynamic Clinical Key:
Kiesselbach's Plexus is the site of over 90% of all anterior pediatric and adult epistaxis. Bleeding is triggered by local trauma (nose picking), low environmental humidity, or mucosal dry cracks. It is managed with direct compression, anterior nasal packaging, or localization and chemical cautery with silver nitrate. Focus on rate-limiting regulatory steps for pharmacological design. Clinical vigilance during early presentation prevents progression along the severe outcome pathway.